著者
古閑 健二郎 大嶋 耐之 河島 進
出版者
日本病院薬剤師会
雑誌
病院薬学 = Journal of the Nippon Hospital Pharmacists Association (ISSN:03899098)
巻号頁・発行日
vol.21, no.2, pp.166-169, 1995-04-10
参考文献数
6
被引用文献数
1

To recognize the existing state of simultaneous use ("Gappo") of Kampo extract medicines, we investigated the medicines from 3099 prescription preparations. The results were as follows: 1) The rate of two and three combined preparations was 10.1% and 0.8%, and combined kinds being 98 and 14, respectively. 2) Rate of non-reducing dose prescriptions among combined preparations was 19.1%. 3) The rate of combined kinds of crude drug from single to three comprised 70% among two combined preparations, and the rate of the major crude drug, Glycyrrhizae Radix, was 25.6%.
著者
川上 英治 二神 幸次郎 定金 典明 西原 茂樹 荒木 博陽 川崎 博巳 五味田 裕
出版者
日本医療薬学会
雑誌
病院薬学 = Journal of the Nippon Hospital Pharmacists Association (ISSN:03899098)
巻号頁・発行日
vol.25, no.1, pp.69-75, 1999-02-10
被引用文献数
8

Pharmacists need to have a clear policy for managing investigational drugs under circumstances that are consistent with Good Clinical Practice. We studied the management and support system for the clinical research of investigational drugs based on the management of investigational drugs. We experienced 126 cases of pharmaceutical consultations in 650 prescriptions for investigational drugs from April 1997 to March 1998. Seven cases which might induce a patient to drop out, were included in pharmaceutical consultations. We found it was important to communicate with all investigators regarding giving adequate prior information to having a clearly defined protocol. Our pharmaceutical program for the clinical research of investigational drugs was thus found to be useful in the management of investigational drugs.